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INTRODUCTION 
Gordon Holmes Syndrome (GDHS) is a rare, but fatal 
autosomal recessive neurodegenerative disorder. It causes 
symptoms of cerebellar ataxia, neuroendocrine failure, and 
commonly dementia. Following a normal childhood 
development, symptoms appear during the teenage years and 
continue to develop in a progressive nature. Typically, patients 
find themselves bed-ridden by their twenties and most die by 
their mid-forties. Recently a study used whole exome 
sequencing that linked mutations in the E3 ligase RNF216 to 
the pathogenesis of the disease [1]. However, despite 
identifying this molecular basis, the biological mechanism 
remains elusive. Thus, our objective was to develop a 
zebrafish model of GDHS and focus on the cerebellum and 
hypothalamus to determine mechanisms that lead to ataxia and 
neuroendocrine failure, respectively. 
METHODS 
Morpholino (MO) microinjections were used to knockdown 
the rnf216 gene in zebrafish embryos. Embryos were 
separated into three treatment groups: uninjected controls, 
vehicle controls, and MO treated (injected with concentrations 
of 1.6 or 5.0g). Upon sacrifice at 48hpf, 3dpf, 5dpf, and 7dpf, 
immunohistochemistry was used to look at the molecular 
markers SV2, which marks synaptic vesicles containing 
neurotransmitters, zebrinII, which marks purkinje cells 
responsible for the regionalization of the cerebellum, the 
apoptotic marker caspase3, and sox2 for progenitor cells. In 
situ hybridizations on 3dpf zebrafish were also performed 
using hypothalamic riboprobes nkx2.1a, hypocretin, and vsnp. 
RESULTS 
Our data show increased SV2+ neurons in the cerebellum of 
1.6ng MO1-rnf216 injected zebrafish at 3dpf (Fig. 1). These 
morphants also show a decreased neuronal population in the 
pan-hypothalamus, indicating developmental dysregulation. 
These results imply that defects occur in a time specific 
manner in our zebrafish model of Gordon Holmes Syndrome, 
which is also morpholino concentration dependent. As well, 
consistent with an increased cell population (SV2+ neurons), 
cell death was not present at this timepoint and no differential 
expression was observed for the apoptotic marker anti-
caspase3. Preliminary data also indicate morphants have  
decreased anti-zebrinII, anti-sox2 and differential hypocretin 
and vsnp expression.  
        
Figure 1. Serial sagittal sections of the cerebellum (7m 
thickness) show SV2+ neuronal elements (green) and the 
outline of the tissue was obtained using the nuclear stain, 
DAPI (blue). SV2+ neurons are increased in the cerebellum of 
rnf216-MO injected zebrafish (1.6g) when compared to 
vehicle and uninjected controls (highlighted with red 
arrowheads). 
 
DISCUSSION AND CONCLUSIONS 
Increased SV2+ neurons in the cerebellum of 1.g rnf216 MO-
injected zebrafish at 3dpf suggests a dysregulation of synaptic 
pruning early in development of these mutants. Synaptic 
pruning is an essential process that refines neuronal circuitry 
by removing unnecessary and unwanted connections in order 
to strengthen more productive ones. Though cellular and 
molecular mechanisms are not very well understood, studies 
have indicated the role of E3 ubiquitin ligases, such as 
RNF216, in regulating the process of synaptic pruning [2]. 
Hence a mutated RNF216 may directly be linked to the 
increased synapses present, as it may not properly function to 
remove the unwanted connections. Combined these findings 
start to provide insight into the etiology behind this disease 
and to further understand the role of RNF216 in implicating 
cerebellar ataxia and neuroendocrine dysregulation.   
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